S2-E7.1 - The Newer Diabetes Drugs and NASH: Modes of Action

from Surfing the MASH Tsunami · host HEP Dynamics LLC

Send us Fan MailJörn Schattenberg reviews modes of action for GLP-1 agonists and SGLT-2 inhibitors and discusses the data that exist in NAFLD and NASH. The group considers scientific issues surrounding the newer diabetes drugs. First, Jörn Schattenberg presented mode-of-action and research data on the two classes of drugs. After this, Wayne Eskridge asked questions from the patient perspective, Louise Campbell explores issues from a holistic perspective and Roger Green raised data points and concepts that arose in earlier episodes of the podcast.

Episode metadata supplied by the publisher feed · Published Feb 20, 2021

Embed this episode

Attribution link and audio player

NOW PLAYING

S2-E7.1 - The Newer Diabetes Drugs and NASH: Modes of Action

0:00 16:57

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Surfing the MASH Tsunami?

This episode is 16 minutes long.

When was this Surfing the MASH Tsunami episode published?

This episode was published on February 20, 2021.

Can I download this Surfing the MASH Tsunami episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!